The Orlando-based company specializes in sleep apnea treatment, ventilators, oxygen, and other home medical equipment, expanding Owens & Minor’s reach in the home healthcare market.
Summary: Owens & Minor Inc is set to acquire Rotech Healthcare, a home-based care provider specializing in sleep apnea treatment, ventilators, and oxygen, for $1.36 billion in cash. This acquisition will expand Owens & Minor’s Patient Direct segment and enhance its presence in the home medical equipment market. Rotech operates in 46 states with over 4,200 employees and generated $750 million in revenue in 2023. The deal aims to strengthen product offerings, support a combined customer base, and improve service for patients with chronic conditions.
Key Takeaways:
- Acquisition Details: Owens & Minor Inc has agreed to acquire Rotech Healthcare, a home-based care business, for $1.36 billion in cash, aiming to expand its Patient Direct segment and strengthen its presence in the home medical equipment market.
- Company Impact: Rotech Healthcare operates in 46 states with over 4,200 employees, generating approximately $750 million in revenue and an EBITDA margin of nearly 30% in 2023.
- Strategic Rationale: Owens and Minor says the acquisition will enhance its product offerings in respiratory, sleep apnea, diabetes, and wound care, support a combined customer base, and improve service for patients with chronic conditions.
Global healthcare solutions company Owens & Minor Inc has entered into a definitive agreement to acquire Rotech Healthcare, a provider of sleep apnea treatment, ventilators, oxygen, and home medical equipment, in a $1.36 billion cash deal.
Orlando, Fla-based Rotech has over 4,200 employees and provides products and services in 46 states through approximately 325 operating locations. In 2023, Rotech generated approximately $750 million in revenue with an EBITDA margin of nearly 30%.
“Rotech squarely fits into our existing Patient Direct segment and directly aligns with the strategy we outlined last December during our Investor Day, supporting our expansion in the very large and fast-growing home-based care space,” says Edward A. Pesicka, president and chief executive officer of Owens & Minor, in a release.
According to Owens & Minor, the strategic rationale for the acquisition includes:
- Strengthens Patient Direct product offerings through expansion across a complementary portfolio including respiratory, sleep apnea, diabetes, and wound care, while providing access to the durable medical equipment market.
- Supports combined customer base, allowing Owens & Minor to better serve providers and payors across an integrated national network.
- Enhances service to patients through the combined suite of complementary product offerings, improving care for patients with chronic conditions in large and fragmented markets.
“The team and I look forward to being part of Owens & Minor due to their commitment to providing best-in-class products and services to patients in their homes. Owens & Minor is a natural home for the Rotech team, and we believe the combination will benefit patients, providers, payors, and employees,” says Robin Menchen, president and chief executive officer of Rotech, in a release.
Photo 106089051 © Casimirokt | Dreamstime.com
